SITALICE-50 MG is an oral anti-diabetic medication containing Sitagliptin, a selective DPP-4 (Dipeptidyl Peptidase-4) inhibitor. It is used for the management of Type 2 Diabetes Mellitus, either as a monotherapy or in combination with other anti-diabetic medications like Metformin or Sulfonylureas. Sitagliptin works by increasing the levels of incretin hormones, which help regulate insulin production in response to meals and reduce the liver’s glucose output. It is well-tolerated, does not generally cause hypoglycemia, and is weight neutral, making it a safe and effective option for long-term glycemic control.